FDA Counter-Offers On Industry CLIA Waiver Proposal
This article was originally published in The Gray Sheet
Executive Summary
After device-makers proposed goals to speed up CLIA waiver reviews, FDA has come back with a compromise offer that would set quicker timelines than current policies but falls short of industry's more aggressive plan.